Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Pimecrolimus
Medication labelPimecrolimus Cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate…
Why this: Advisory · dailymed-prescription
Pimecrolimus Cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable. Pimecrolimus Cream, 1% is not indicated for use in children less than 2 years of age [see Warnings and Precautions (5.1), Use in Specific Populations (8.4)].
- generic_name
- pimecrolimus
- product_names
- Pimecrolimus
- ndc
- 68682-112, 68682-111, 68682-110, 68682-112-03, 68682-111-02, 68682-110-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en